Cargando…
Predictors of right ventricular function improvement with sacubitril/valsartan in a real‐life population of patients with chronic heart failure
BACKGROUND: Observational studies have demonstrated that treatment with sacubitril/valsartan may improve left ventricular (LV) systolic and diastolic function in subjects with reduced LV ejection fraction (LVEF) in real‐world studies. Subjects with heart failure and reduced EF (HFrEF), however, are...
Autores principales: | Correale, Michele, Mazzeo, Pietro, Magnesa, Michele, Fortunato, Martino, Tricarico, Lucia, Leopizzi, Alessandra, Mallardi, Adriana, Mennella, Raffaele, Tucci, Salvatore, Brunetti, Natale Daniele |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9292438/ https://www.ncbi.nlm.nih.gov/pubmed/34510702 http://dx.doi.org/10.1111/cpf.12726 |
Ejemplares similares
-
Left Atrial Functional Remodeling in Patients with Chronic Heart Failure Treated with Sacubitril/Valsartan
por: Correale, Michele, et al.
Publicado: (2023) -
Sacubitril/valsartan improves right ventricular function in a real-life population of patients with chronic heart failure: The Daunia Heart Failure Registry
por: Correale, Michele, et al.
Publicado: (2020) -
Switch to SGLT2 Inhibitors and Improved Endothelial Function in Diabetic Patients with Chronic Heart Failure
por: Correale, Michele, et al.
Publicado: (2021) -
The Evolving Phenotypes of Cardiovascular Disease during COVID-19 Pandemic
por: Correale, Michele, et al.
Publicado: (2021) -
Effects of Sacubitril/Valsartan on the Renal Resistance Index
por: Gioia, Margherita Ilaria, et al.
Publicado: (2022)